✦ LIBER ✦

Effectiveness of Liver Metastasectomies in Patients With Metastatic Colorectal Cancer Treated With FIr-B/FOx Triplet Chemotherapy Plus Bevacizumab

✍ Scribed by Gemma Bruera; Katia Cannita; Felice Giuliante; Paola Lanfiuti Baldi; Roberto Vicentini; Paolo Marchetti; Gennaro Nuzzo; Adelmo Antonucci; Corrado Ficorella; Enrico Ricevuto

Book ID: 116365648
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 363 KB
Volume: 11
Category: Article
ISSN: 1533-0028
DOI: 10.1016/j.clcc.2011.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Worse prognosis ofKRASc.35 G > A mutant

Worse prognosis ofKRASc.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx)

✍ Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 219 KB

Prognostic value ofKRASgenotype in metas

Prognostic value ofKRASgenotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease

✍ Gemma Bruera, Katia Cannita, Daniela Di Giacomo, Aude Lamy, Giancarlo Troncone, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 234 KB

Prognostic Value of the Combination of C

Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab

✍ Sastre, Javier; Vidaurreta, Marta; Gómez, Auxiliadora; Rivera, Fernando; Massutí 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 686 KB

3049 POSTER Management of hypertension (

3049 POSTER Management of hypertension (HTN) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV) plus chemotherapy (CT)

✍ M. Kozloff; J. Hainsworth; S. Badarinath; A. Cohn; P. Flynn; W. Dong; D. Purdie; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Histopathologic evaluation of liver meta

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

✍ Loupakis, F; Schirripa, M; Caparello, C; Funel, N; Pollina, L; Vasile, E; Cremol 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 638 KB

Multicenter phase II study of second-lin

Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy

✍ Yong Sang Hong, Jeeyun Lee, Kyu-pyo Kim, Jae-Lyun Lee, Young Suk Park, Joon Oh P 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 260 KB